Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $114.74
-
Support level$94.52
-
Resistance levelN/A
-
Beta0.3
-
RSI (14-day)84.2
- GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- With a 59.1 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- GILD is one of this month's top performers with a return of 16.6 percent, beating 90 percent of stocks in the S&P-100.
- Up 2.9 percent, GILD is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- With RSI > 70, GILD is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$63.15 | $115.99 | 98.2% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$83.83 | $98.09 | $105.98 | $111.77 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week8.6%
-
In the next month16.1%
-
In the next year49.1%
Period | Value |
---|---|
Historical (5 year) | 26.2% |
Last month | 24.3% |
Current estimate | 31.8% |
Next month forecast | 28.5% |